The Dysantic contains plant extracts enhancing the multiplication of Lactobacilli, extract of St. John’s bread seed (Ceratonia siliqua) – having bactericide and immunstimulating effect, and of thyme (Thymus vulgaris) – having bactericide effect.
In the intestine of the healthy pigs, the Gram positive anaerobic homo-, and heterofermentative lactic acid producing, and the anaerobic Gram negative bacteria and symbiotic yeasts are dominant. Furthermore a small number (not more than 0.01% of the total flore) of pathogenic bacteria are also present. The increase of the ratio of the pathogenic agents may lead to gastrointestinal diseases. The active substance of the Dysantic significantly hinders the growth of the pathogen microorganisms.
Results of the field tests of the DYSANTIC
The intestinal flora is in a healthy equilibrium (eubiosis) until the negative influence of various environmental factors (stressors) a propagation of facultative pathogens (Clostridia, Salmonellae, enteropathogenic coli, Brachyspirae, etc.) disturbing this equilibrium (dysbiosis).
Factors which can negatively affect the health status of the animals:
The stressors occurring during the fattening period, can seriously disturb the equilibrium of the intestinal microflore, opening the gate to growth for the pathogenic agents and as a consequence development of serious diseases.
One of these diseases causing significant economic losses is the dysenterial diarrhoea of pigs which can occur in several cases after weaning and also in the parent stock.
WITH THE USE OF DYSANTIC THE PROFITABILITY OF PIG FARMING IMPROVES!
For preventing the gastro-intestinal sicknesses: 1-2 kg/ ton of feed.
Please take into consideration that the effective dose of the product is affected by the actual farming and feeding conditions. It is recommended to determine the dose specificly to the farm and use the product between the proposed limits.
In the framework of the Central Hungarian Operational Program (Közép-Magyarországi Operatív Program), Dr. BATA Hungarian Canadian Biotechnology Research Development Ltd. was awarded 97 500 000 HUF of subsidies from EU and domestic central budget sources to develop environmentally friendly, food- safety-precision trace element of premixes for the commercial livestock.
The project’s total budget is 150 million HUF.
Our company completed the project KMOP-1.1.1-07/1-2008-0013 on the 31st May 2011.Continue reading
The Dr. Bata Ltd. won 318.66 million HUF non-refundable funding on the project “Funding for market-oriented research and development”. The investment budget of 480.33 million HUF helped to develop a complex, biotechnology based, acid-resistant, protected NSP enzymproduct development of probiotic effect. Throughout this project the solution was found for the economical and environment friendly treatment and utilization of biological, rich in fiber by-products.Continue reading
In the framework of the Central Hungarian Operational Program, the Dr BATA Hungarian Canadian Biotechnology Research Development Ltd. was awarded 115 million HUF in support of the project "Support for Enterprise Innovation". In the framework of the project, we applied for the development of a herbal combination-based product family against digestive diseases in pigs and help for the market access of the developed product. The total budget of the project was 255.56 million HUF.Continue reading